These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 2585733

  • 21. [Survival in ovarian cancer treated in a gynecological department of a central hospital].
    Dragsted NO, Nørgaard M, Bøsling KB.
    Ugeskr Laeger; 1997 May 12; 159(20):3003-9. PubMed ID: 9190729
    [Abstract] [Full Text] [Related]

  • 22. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.
    Forum (Genova); 2000 May 12; 10(4):323-32. PubMed ID: 11535983
    [Abstract] [Full Text] [Related]

  • 23. A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancer.
    Kohn EC, Sarosy GA, Davis P, Christian M, Link CE, Ognibene FP, Sindelar WF, Jacob J, Steinberg SM, Premkumar A, Reed E.
    Gynecol Oncol; 1996 Aug 12; 62(2):181-91. PubMed ID: 8751547
    [Abstract] [Full Text] [Related]

  • 24. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
    Rubin SC, Wong GY, Curtin JP, Barakat RR, Hakes TB, Hoskins WJ.
    Obstet Gynecol; 1993 Jul 12; 82(1):143-7. PubMed ID: 8515915
    [Abstract] [Full Text] [Related]

  • 25. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY, Zhang R, Huang MN, Li N, Wang GX, Liu LY.
    Ai Zheng; 2003 Apr 12; 22(4):424-7. PubMed ID: 12704005
    [Abstract] [Full Text] [Related]

  • 26. [Results of cisplatin-based polychemotherapy and analysis of prognostic factors in ovarian cancer. Apropos of 106 cases].
    Maloisel F, Dufour P, Bergerat JP, Bellocq JP, Duclos B, Boilletot A, Herbrecht R, Dellenbach P, Renaud R, Ritter P.
    Bull Cancer; 1989 Apr 12; 76(10):1083-93. PubMed ID: 2635636
    [Abstract] [Full Text] [Related]

  • 27. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Wimberger P, Lehmann N, Kimmig R, Burges A, Meier W, Du Bois A, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Gynecol Oncol; 2007 Jul 12; 106(1):69-74. PubMed ID: 17397910
    [Abstract] [Full Text] [Related]

  • 28. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, Rubin SC, Muggia F, McGuire WP, Gynecologic Oncology Group.
    J Clin Oncol; 2008 Jan 01; 26(1):83-9. PubMed ID: 18025437
    [Abstract] [Full Text] [Related]

  • 29. A new prognostic model for FIGO stage 1 epithelial ovarian cancer.
    Obermair A, Fuller A, Lopez-Varela E, van Gorp T, Vergote I, Eaton L, Fowler J, Quinn M, Hammond I, Marsden D, Proietto A, Carter J, Davy M, Tripcony L, Abu-Rustum N.
    Gynecol Oncol; 2007 Mar 01; 104(3):607-11. PubMed ID: 17092548
    [Abstract] [Full Text] [Related]

  • 30. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
    Sevelda P.
    Wien Klin Wochenschr Suppl; 1990 Mar 01; 183():3-29. PubMed ID: 2145702
    [Abstract] [Full Text] [Related]

  • 31. [Developments in the therapy of advanced FIGO III ovarian cancer].
    Kuhn W, Jänicke F, Pache L, Hölscher M, Schattenmann G, Schmalfeldt B, Anderl H, Schüle G, Dettmar P, Siewert JR.
    Geburtshilfe Frauenheilkd; 1993 May 01; 53(5):293-302. PubMed ID: 8514099
    [Abstract] [Full Text] [Related]

  • 32. [Analysis of prognostic factors of epithelial ovarian carcinoma].
    Shao SL, Liu XS.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Feb 01; 45(2):132-6. PubMed ID: 20420785
    [Abstract] [Full Text] [Related]

  • 33. Surgical stage IV endometrial carcinoma: a study of 47 cases.
    Goff BA, Goodman A, Muntz HG, Fuller AF, Nikrui N, Rice LW.
    Gynecol Oncol; 1994 Feb 01; 52(2):237-40. PubMed ID: 8314145
    [Abstract] [Full Text] [Related]

  • 34. [Importance of clinically prognostic factors in the treatment of advanced ovarian carcinoma].
    Albrecht M, Goepel E, Simon WE, Trams G.
    Geburtshilfe Frauenheilkd; 1985 Jul 01; 45(7):482-7. PubMed ID: 2993094
    [Abstract] [Full Text] [Related]

  • 35. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C, Greggi S, Tambaro R, Losito S, Iodice F, Di Maio M, Ferrari E, Falanga M, Formato R, Iaffaioli VR, Pignata S.
    Anticancer Res; 2005 Jul 01; 25(5):3501-5. PubMed ID: 16101169
    [Abstract] [Full Text] [Related]

  • 36. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, Fracchioli S, Durando A, Arisio R, Diamandis EP.
    Clin Cancer Res; 2000 Aug 01; 6(8):3260-70. PubMed ID: 10955812
    [Abstract] [Full Text] [Related]

  • 37. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
    Karam AK, Chiang JW, Fung E, Nossov V, Karlan BY.
    Gynecol Oncol; 2009 Aug 01; 114(2):246-52. PubMed ID: 19500821
    [Abstract] [Full Text] [Related]

  • 38. Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.
    Kuhn W, Pache L, Schmalfeldt B, Dettmar P, Schmitt M, Jänicke F, Graeff H.
    Gynecol Oncol; 1994 Dec 01; 55(3 Pt 1):401-9. PubMed ID: 7835780
    [Abstract] [Full Text] [Related]

  • 39. [Prognosis and prognostic factor analysis epithelial ovarian cancer].
    Wen H, Sun W, Guo Y.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar 01; 32(3):159-62. PubMed ID: 9596891
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.